For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Now imagine that sensation amplified a hundredfold, and you’ve got the Guardian Angel Thrift Store experience in Fuquay-Varina, North Carolina. This isn’t your run-of-the-mill secondhand shop where ...

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

As more businesses rely on technology, CTOs and CEOs need to speak the same language.

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

By integrating NVIDIA’s digital twins, foundation models and perception AI, Multiply Labs is pioneering a new era of robotic ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Andrea Barnes Andrea Barnes is a writer covering large cleaning appliances.

SEC and White House have supported more investor product choices Concerns over investor understanding of complex products Private assets in retirement plans raise liquidity and valuation issues SEC, ...

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...